Quality Control reagents for Biochem.Lab ישראל - עברית - Ministry of Health

quality control reagents for biochem.lab

sigma-aldrich israel - כלל האוכלוסיה - חומרי אבטחת איכות למעבדות

גאמונקס  - סי ישראל - עברית - Ministry of Health

גאמונקס - סי

padagis israel agencies ltd, israel - immunoglobulins, normal human - תמיסה לאינפוזיה - immunoglobulins, normal human 0.1 g/ml - immunoglobulins, normal human, for intravascular adm. - immunoglobulins, normal human, for intravascular adm. - gamunex is indicated as replacement therapy of primary immunodeficiency (pi) states in which severe impaiment of antibody forming capacity has been shown, such as congential agammaglobulinemia, common variable immunodeficiency, x-limked immunodeficiency with hyper igm, wiskott- aldrich syndrom, and severed combined immunodeficiencies. gamunex is also indicated in idiopathic thrombocytopenia purpura (itp) to raise platelet counts to prevent bleeding or to allow a patient with itp to undergo surgery.treatment of chronic inflammatory demyelinating polyneuropathy (cidp).

תרים 100 ישראל - עברית - Ministry of Health

תרים 100

unipharm ltd, israel - sildenafil as citrate - טבליות מצופות פילם - sildenafil as citrate 100 mg - sildenafil

תרים 50 ישראל - עברית - Ministry of Health

תרים 50

unipharm ltd, israel - sildenafil as citrate - טבליות מצופות פילם - sildenafil as citrate 50 mg - sildenafil

פריוויג'ן ישראל - עברית - Ministry of Health

פריוויג'ן

csl behring ltd., israel - immunoglobulins, normal human - תמיסה לאינפוזיה - immunoglobulins, normal human 100 g/l - immunoglobulins, normal human, for intravascular adm. - immunoglobulins, normal human, for intravascular adm. - 1. replacement therapy in- primary immunodeficiency syndromes such as:- congenital agammaglobulinaemia and hypogammaglobulinaemia- common variable immunodeficiency- severe combined immunodeficiency- wiskott-aldrich syndrome- myeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections-children with congenital aids and recurrent infections2. immunomodulation- immune thrombocytopenic purpura (itp) in children or adults at high risk of bleeding or prior to surgical interventions to correct the platelet count-guillain-barr? syndrome- kawasaki disease3. allogeneic bone marrow transplantation

אלביב שמפו + מרכך 2 ב- 1 נגד קשקשים לשיער רגיל ישראל - עברית - Ministry of Health

אלביב שמפו + מרכך 2 ב- 1 נגד קשקשים לשיער רגיל

אינטרביוטי קוסמטיקס ישראל בעמ - שמפו נגד קשקשים

גאמאגארד S/D אימונוגלובולין תוך ורידי 2.5 גר' ישראל - עברית - Ministry of Health

גאמאגארד s/d אימונוגלובולין תוך ורידי 2.5 גר'

teva medical marketing ltd. - immunoglobulin normal human 50 mg/ml - powder for solution for injection - immunoglobulins, normal human, for intravascular adm. - replacement therapy in:• primary immunodeficiency syndromes (pid) such as: - congenital agammaglobulinaemia and hypogammaglobulinaemia; - common variable immunodeficiency; - severe combined immunodeficiency; - wiskott aldrich syndrome.• myeloma or chronic lymphocytic leukaemia (cll) with severe secondary hypogammaglobulinaemia and recurrent infections.• children with congenital aids and recurrent infections.immunomodulation• idiopathic thrombocytopenic purpura (itp), in children or adults at high risk of bleeding or prior to surgery to correct the platelet count.• guillain barr? syndrome. in this case gammagard s/d (solvent/detergent) is only indicated in patients showing one of the following symptoms: - progressive paresis (the patient cannot walk more than 10 m on his own); - signs of a respiratory disorder (clinically observed or demonstrated by measuring the vital capacity at the patient’s bed); - signs of oropharyngeal paresis.• kawasaki disease.allogeneic bone marrow transplantation

גאמאגארד S/D אימונוגלובולין תוך ורידי 5 גר' ישראל - עברית - Ministry of Health

גאמאגארד s/d אימונוגלובולין תוך ורידי 5 גר'

teva medical marketing ltd. - immunoglobulin normal human 50 mg/ml - powder for solution for injection - immunoglobulins, normal human, for intravascular adm. - replacement therapy in:• primary immunodeficiency syndromes (pid) such as: - congenital agammaglobulinaemia and hypogammaglobulinaemia; - common variable immunodeficiency; - severe combined immunodeficiency; - wiskott aldrich syndrome.• myeloma or chronic lymphocytic leukaemia (cll) with severe secondary hypogammaglobulinaemia and recurrent infections.• children with congenital aids and recurrent infections.immunomodulation• idiopathic thrombocytopenic purpura (itp), in children or adults at high risk of bleeding or prior to surgery to correct the platelet count.• guillain barr? syndrome. in this case gammagard s/d (solvent/detergent) is only indicated in patients showing one of the following symptoms: - progressive paresis (the patient cannot walk more than 10 m on his own); - signs of a respiratory disorder (clinically observed or demonstrated by measuring the vital capacity at the patient’s bed); - signs of oropharyngeal paresis.• kawasaki disease.allogeneic bone marrow transplantation